2010
DOI: 10.1016/j.critrevonc.2009.04.008
|View full text |Cite
|
Sign up to set email alerts
|

The beneficial role of vitamin D and its analogs in cancer treatment and prevention

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
21
1
1

Year Published

2011
2011
2018
2018

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 32 publications
(26 citation statements)
references
References 112 publications
3
21
1
1
Order By: Relevance
“…39 In addition, the active metabolite of vitamin D, 1,25-dihydroxyvitamin D3, was found to have the ability to avoid cell proliferation. 40 We found a prevalence of cervical HPV infection of 28.4%, which was higher than in some studies. Tam et al 21 found that 12.5% of SLE patients had a persistently high risk of HPV, which increased to 25% after three years.…”
Section: Discussioncontrasting
confidence: 73%
“…39 In addition, the active metabolite of vitamin D, 1,25-dihydroxyvitamin D3, was found to have the ability to avoid cell proliferation. 40 We found a prevalence of cervical HPV infection of 28.4%, which was higher than in some studies. Tam et al 21 found that 12.5% of SLE patients had a persistently high risk of HPV, which increased to 25% after three years.…”
Section: Discussioncontrasting
confidence: 73%
“…Growing evidence further documents a role for vitamin D in reducing risk of chronic diseases including some cancers [25], type 1 [6, 7] and type 2 diabetes mellitus [8], and multiple sclerosis [9, 10] Vitamin D may also be protective against cardiovascular disease [CVD] [1, 1113] myocardial dysfunction [14], and hypertension in middle-aged and older women [15]. In children, vitamin D is especially important because of its vital role in bone mineralization [16, 17], insulin sensitivity in obese children and adolescents [18], and cardiac health [19].…”
Section: Introductionmentioning
confidence: 99%
“…[6][7][8] [10][11][12][13][14][15] Several VDR single nucleotide polymorphisms have been described 6,16 ; although most studies found no associations between these VDR single nucleotide polymorphisms and prostate cancer risk, [16][17][18][19] two studies found that men with low 25(OH)D levels and the BsmI BB allele had a lower risk of prostate cancer. 18,19 Men with low 25(OH)D levels and the less functional FokI f allele had an almost two-fold increase in risk for total prostate cancer compared with men with the FokI FF/Ff allele and high 25(OH)D levels; the association was even stronger for advanced-stage or high-grade disease.…”
Section: Introductionmentioning
confidence: 99%